Skip to main content

Advertisement

SpringerLink
Log in

Complementary and alternative treatments for childhood headaches

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Parents frequently ask health care professionals to provide “natural” migraine care for their children and often use herbs, minerals, vitamins, and supplements to treat their children’s migraines, thinking that these over-the-counter alternatives are less toxic than prescription medications. The only randomized controlled trial on any alternative treatment for pediatric migraine is for magnesium, and the results were equivocal. Results of two other uncontrolled trials of magnesium, one for migraine and one for episodic tension-type headache, were positive. There is one positive uncontrolled trial each for coenzyme Q10 and Petasites for prevention of pediatric migraine. There are no trials to indicate the safety or efficacy of riboflavin or feverfew for pediatric headache.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Welch KMA, Ramadan, NM: Mitochondria, magnesium and migraine. J Neurol Sci 1995, 134:9–14.

    Article  PubMed  CAS  Google Scholar 

  2. Wang F, Van Den Eeden SK, Ackerson LM, et al.: Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebocontrolled trial. Headache 2003, 43:601–610.

    Article  PubMed  Google Scholar 

  3. Castelli S, Meossi C, Domenici R, et al.: Magnesium in the prophylaxis of primary headache and other periodic disorders in children [in Italian]. Pediatr Med Chir 1993, 15:481–488.

    PubMed  CAS  Google Scholar 

  4. Grazzi L, Andrasik F, Usai S, Bussone G: Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up. Neurol Sci 2007, 28:148–150.

    Article  PubMed  CAS  Google Scholar 

  5. Peikert A, Wilimzig C, Kohne-Volland: Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996, 16:257–263.

    Article  PubMed  CAS  Google Scholar 

  6. Facchinetti F, Sances G, Borella P, et al.: Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991, 31:298–301.

    Article  PubMed  CAS  Google Scholar 

  7. Pffafenrath V, Wessely P, Meyer C, et al.: Magnesium in the prophylaxis of migraine—a double-blind, placebo-controlled study. Cephalalgia 1996, 16:436–440.

    Article  Google Scholar 

  8. Cady RK, Farmer K, Altura BT, et al.: The effect of magnesium on the responsiveness of migraineurs to a 5-HT1 agonist [abstract]. Neurology 1998, 50(Suppl 4):A340.

    Google Scholar 

  9. Mauskop A, Altura BT, Cracco RQ, Altura BM: Intravenous magnesium sulfate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci (Lond) 1995, 89:633–636.

    CAS  Google Scholar 

  10. Mauskop A, Altura B: Role of magnesium in the pathogenesis and treatment of migraine. Clin Neurosci 1998, 5:24–27.

    PubMed  CAS  Google Scholar 

  11. Bigal ME, Bordini CA, Tepper SJ, Speciali JG: Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 2002, 22:345–353.

    Article  PubMed  CAS  Google Scholar 

  12. Hershey AD, Powers SW, Vockell AL, et al.: Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007, 47:73–80.

    Article  PubMed  Google Scholar 

  13. Sandor PS, Di Clemente L, Coppola G, et al.: Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005, 64:713–715.

    PubMed  CAS  Google Scholar 

  14. Rozen TD, Oshinsky ML, Gebeline CA, et al.: Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia 2002, 22:137–141.

    Article  PubMed  CAS  Google Scholar 

  15. Sheftell F, Rapoport A, Weeks R, et al.: Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers. Headache 2000, 40:158–163.

    Article  PubMed  CAS  Google Scholar 

  16. Thomet OA, Wiesmann UN, Schapowal A, et al.: Role of petasin in the potential anti-inflammatory activity of a plant extract of Petasites hybridus. Biochem Pharmacol 2001, 61:1041–1047.

    Article  PubMed  CAS  Google Scholar 

  17. Pothmann R, Danesch U: Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache 2005, 45:196–203.

    Article  PubMed  Google Scholar 

  18. Grossman M, Schmidramsl H: An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther 2000, 38:430–435.

    Google Scholar 

  19. Lipton RB, Gobel H, Einhäupl KM, et al.: Petasites hybridus root (butterbur) is an effective treatment for migraine. Neurology 2004, 63:2240–2244.

    PubMed  CAS  Google Scholar 

  20. Schoenen J, Jacquy J, Lenaerts M: Effectiveness of highdose riboflavin in migraine prophylaxis. Neurology 1998, 50:466–470.

    PubMed  CAS  Google Scholar 

  21. Maizels M, Blumenfeld A, Burchette R: A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 2004, 44:885–890.

    Article  PubMed  Google Scholar 

  22. Hepinstall S, White A, Williamson L, Mitchell JRA: Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leukocytes. Lancet 1985, i:1071–1074.

    Article  Google Scholar 

  23. Johnson ES, Kadam NP, Hylands DM, Hylands PJ: Efficacy of feverfew as prophylactic treatment of migraine. Br Med J 1985, 291:569–573.

    Article  CAS  Google Scholar 

  24. Vogler BK, Pittler MH, Ernst E: Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia 1998, 18:704–708.

    Article  PubMed  CAS  Google Scholar 

  25. Pfaffenrath V, Diener HC, Fischer M, et al.: The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis—a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002, 22:523–532.

    Article  PubMed  CAS  Google Scholar 

  26. Diener HC, Pfaffenrath V, Schnitker J, et al.: Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention—a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 2005, 25:1031–1041.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Headache and Pain, T33, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Stewart J. Tepper

Authors
  1. Stewart J. Tepper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stewart J. Tepper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tepper, S.J. Complementary and alternative treatments for childhood headaches. Current Science Inc 12, 379–383 (2008). https://doi.org/10.1007/s11916-008-0064-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-008-0064-8

Keywords

Search

Navigation